Contact
Please use this form to send email to PR contact of this press release:
Celsion Announces Enrollment Completion for Pivotal Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer
TO:
Please use this form to send email to PR contact of this press release:
Celsion Announces Enrollment Completion for Pivotal Phase III OPTIMA Study of ThermoDox® in Primary Liver Cancer
TO: